1. Home
  2. HCM vs ETY Comparison

HCM vs ETY Comparison

Compare HCM & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • ETY
  • Stock Information
  • Founded
  • HCM 2000
  • ETY 2006
  • Country
  • HCM Hong Kong
  • ETY United States
  • Employees
  • HCM N/A
  • ETY N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • ETY Finance Companies
  • Sector
  • HCM Health Care
  • ETY Finance
  • Exchange
  • HCM Nasdaq
  • ETY Nasdaq
  • Market Cap
  • HCM 2.3B
  • ETY 2.4B
  • IPO Year
  • HCM N/A
  • ETY N/A
  • Fundamental
  • Price
  • HCM $13.52
  • ETY $15.38
  • Analyst Decision
  • HCM Hold
  • ETY
  • Analyst Count
  • HCM 1
  • ETY 0
  • Target Price
  • HCM $19.00
  • ETY N/A
  • AVG Volume (30 Days)
  • HCM 85.0K
  • ETY 247.3K
  • Earning Date
  • HCM 02-26-2025
  • ETY 01-01-0001
  • Dividend Yield
  • HCM N/A
  • ETY 7.21%
  • EPS Growth
  • HCM N/A
  • ETY N/A
  • EPS
  • HCM N/A
  • ETY N/A
  • Revenue
  • HCM $610,806,000.00
  • ETY N/A
  • Revenue This Year
  • HCM N/A
  • ETY N/A
  • Revenue Next Year
  • HCM $18.76
  • ETY N/A
  • P/E Ratio
  • HCM N/A
  • ETY N/A
  • Revenue Growth
  • HCM N/A
  • ETY N/A
  • 52 Week Low
  • HCM $13.00
  • ETY $10.59
  • 52 Week High
  • HCM $21.92
  • ETY $13.46
  • Technical
  • Relative Strength Index (RSI)
  • HCM 40.71
  • ETY 58.63
  • Support Level
  • HCM $13.10
  • ETY $15.10
  • Resistance Level
  • HCM $13.92
  • ETY $15.60
  • Average True Range (ATR)
  • HCM 0.38
  • ETY 0.21
  • MACD
  • HCM 0.02
  • ETY 0.02
  • Stochastic Oscillator
  • HCM 37.96
  • ETY 67.86

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.

Share on Social Networks: